Ledger.Open graph →
SEC Form D · filed December 18, 2023

Bridge Therapeutics, Inc

Offering
$1.5M
Sold
$321K
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
BIRMINGHAM, AL
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (12)

Joseph P. Mullin · New York, NYDirectorElizabeth G. Kelley · Lucedale, MSDirectorTimothy G. Peara · Asheville, NCExecJames G. Sullivan · Birmingham, ALExec · DirectorChristopher P. Palutis · Richmond, KYDirectorJason P. Bailey · Keller, TXDirectorChristopher P. Palutis · Richmond, KYDirectorJoseph P. Mullin · New York, NYDirectorElizabeth G. Kelley · Lucedale, MSDirectorJason P. Bailey · Keller, TXDirectorTimothy G. Peara · Asheville, NCExecJames G. Sullivan · Birmingham, ALExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗